Scandinavian Medical Solutions A/S (CPH: SMSMED)
Denmark
· Delayed Price · Currency is DKK 5.50
-0.10 (-1.79%)
Dec 19, 2024, 4:59 PM CET
CPH: SMSMED Revenue
In the fiscal year ending September 30, 2024, Scandinavian Medical Solutions had annual revenue of 226.68M DKK with 18.56% growth. Scandinavian Medical Solutions had revenue of 124.12M in the half year ending September 30, 2024, with 112.00% growth.
Revenue
226.68M
Revenue Growth
+18.56%
P/S Ratio
0.68
Revenue / Employee
8.72M
Employees
20
Market Cap
153.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 226.68M | 35.49M | 18.56% |
| Sep 30, 2023 | 191.19M | 80.66M | 72.98% |
| Sep 30, 2022 | 110.53M | 38.89M | 54.29% |
| Sep 30, 2021 | 71.64M | 29.69M | 70.78% |
| Sep 30, 2020 | 41.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 270.58B |
| Coloplast A/S | 27.03B |
| Genmab A/S | 19.84B |
| Demant A/S | 22.84B |
| Zealand Pharma A/S | 76.87M |
| H. Lundbeck A/S | 21.44B |
| H. Lundbeck A/S | 21.44B |
| ALK-Abelló A/S | 5.38B |